Angioid streaks, clinical course, complications, and current therapeutic management
Open Access
- 1 December 2008
- journal article
- review article
- Published by Taylor & Francis in Therapeutics and Clinical Risk Management
- Vol. 5 (1) , 81-89
- https://doi.org/10.2147/tcrm.s4682
Abstract
Angioid streaks, clinical course, complications, and current therapeutic management Ilias Georgalas1, Dimitris Papaconstantinou2, Chrysanthi Koutsandrea2, George Kalantzis2, Dimitris Karagiannis2, Gerasimos Georgopoulos2, Ioannis Ladas21Department of Ophthalmology, “G. Gennimatas” Hospital of Athens, NHS, Athens, Greece; 2Department of Ophthalmology, “G. Gennimatas” Hospital of Athens, University of Athens, Athens, Greece Angioid streaks are visible irregular crack-like dehiscences in Bruch’s membrane that are associated with atrophic degeneration of the overlying retinal pigmented epithelium. Angioid streaks may be associated with pseudoxanthoma elasticum, Paget’s disease, sickle-cell anemia, acromegaly, Ehlers–Danlos syndrome, and diabetes mellitus, but also appear in patients without any systemic disease. Patients with angioid streaks are generally asymptomatic, unless the lesions extend towards the foveola or develop complications such as traumatic Bruch’s membrane rupture or macular choroidal neovascularization (CNV). The visual prognosis in patients with CNV secondary to angioid streaks if untreated, is poor and most treatment modalities, until recently, have failed to limit the devastating impact of CNV in central vision. However, it is likely that treatment with antivascular endothelial growth factor, especially in treatment-naive eyes to yield favorable results in the future and this has to be investigated in future studies.Keywords: angioid streaks, pseudoxanthoma elasticum, choroidal neovascularizationKeywords
This publication has 60 references indexed in Scilit:
- Long-term control of choroidal neovascularisation secondary to angioid streaks treated with intravitreal bevacizumab (Avastin)British Journal of Ophthalmology, 2008
- Intravitreal bevacizumab (Avastin) treatment of choroidal neovascularisation in patients with angioid streaksBritish Journal of Ophthalmology, 2008
- Intravitreal Bevacizumab (Avastin) for Choroidal Neovascularization in Angioid Streaks: A Case SeriesOphthalmologica, 2008
- Anti-VEGF therapy: comparison of current and future agentsEye, 2008
- Photodynamic therapy in the anti-VEGF eraBritish Journal of Ophthalmology, 2007
- Fundus Autofluorescence in Patients with Pseudoxanthoma ElasticumOphthalmology, 2006
- Verteporfin Photodynamic Therapy of Choroidal Neovascularization in Angioid StreaksOphthalmology, 2005
- MACULAR TRANSLOCATION WITH 360-DEGREE PERIPHERAL RETINECTOMYRetina, 2001
- Initial experience of inferior limited macular translocation for subfoveal choroidal neovascularization resulting from causes other than age-related macular degenerationAmerican Journal of Ophthalmology, 2001
- Ocular findings of elderly cases of homozygous sickle-cell disease in Jamaica.British Journal of Ophthalmology, 1976